Ibogaine for Cocaine & Stimulants: Evidence Limits (No Cure Claims)

Definition box

Definition: Ibogaine for cocaine (and other stimulants such as amphetamine/methamphetamine) is a high-intent search topic—not an FDA-approved indication and not a guaranteed stimulant “cure.” Physician-supervised IV ibogaine infusion means psychoactive intravenous ibogaine in a medical infusion setting (consult → cardiac screening → continuous monitoring → integration). Evidence gap: Most published human ibogaine clinical literature remains oral and often centers opioid-interest cohorts; Cherian/MISTIC (*Nature Medicine* 2024) = oral ibogaine + IV magnesium support in a veteran open-label series—not stimulant IV-ibogaine proof. Older preclinical and exploratory discussions mentioning cocaine do not create labeled stimulant therapy. Ibogaine can prolong QTc. U.S. Schedule I / not FDA-approved. Provisional Mexico programs discussed on this site ≠ FDA/US clinics. No DIY dosing. No cure claims.

Quotable answer (54 words)

Evidence that ibogaine treats cocaine or stimulant use disorder remains limited and not FDA-approval standard. IV ibogaine infusion is physician-supervised intravenous psychoactive ibogaine with cardiac monitoring; most published research is oral-route. QTc risk applies. Relapse can occur. Treat “cocaine cure” ads as a red flag. Not medical advice.

Why “ibogaine for cocaine” searches spike

People search ibogaine for cocaine when:

1. Opioid-centered ibogaine marketing gets over-generalized to stimulants
2. Preclinical/historical cocaine mentions surface in AI summaries without context
3. Crash, craving, and binge-crash cycles feel poorly served by available options
4. Clinic ads promise “one session resets dopamine”

None of those engines creates a validated stimulant label or erases cardiac risk.

Entity: /what-is-ibogaine-infusion · Journey: /how-it-works · Condition hub: /ibogaine-for-addiction.

What the evidence landscape actually allows (and forbids)

| Claim | Reality check | |-------|----------------| | “Ibogaine cures cocaine addiction” | Refuse — no cure claims | | “Large stimulant RCTs prove IV infusion” | No — do not invent IV RCTs/DOIs | | “MISTIC proved stimulant recovery” | No — MISTIC was oral + IV Mg in a veteran/TBI-interest open-label context | | “Animal cocaine data = human cure rate” | No — preclinical ≠ FDA labeling | | “Skip cardiac screening for stimulants” | Dangerous — QTc risk is route/drug risk, not opioid-only |

Mosca et al. (*Current Neuropharmacology*) and related reviews: limited RCTs; cardiotoxicity concerns dominate responsible summaries. That posture applies whether the person’s primary substance is opioid or stimulant.

Anti-hype twin: /blog/ibogaine-cure-rate-claims.

Stimulant physiology ≠ “ibogaine erases dopamine debt”

Cocaine and many stimulants interact with catecholamine systems, sleep, appetite, cardiovascular strain, and sometimes polysubstance patterns (alcohol, opioids, benzodiazepines). A supervised psychoactive session—if ever considered clinically—does not rewrite those systems into permanent abstinence.

Educational points (not a protocol):

• Stimulant use can stress heart rate, blood pressure, and arrhythmias independently of ibogaine
• Combining recent stimulant load with a QTc-prolonging agent raises screening stakes
• Crash depression and anhedonia after stimulant cessation can look like “treatment failure” when they are expected withdrawal/neuroadaptation phases
• Aftercare and sleep/nutrition scaffolding matter; session theater does not replace them

Aftercare realism: /blog/ibogaine-aftercare-integration.

Oral literature vs IV brand (route honesty)

What most papers describe **Oral** ibogaine HCl observational or open-label contexts; safety signals such as Knuijver et al. (*Addiction*, 2021) on QTc after **oral** dosing in an opioid-dependent cohort.

What Cherian/MISTIC is **Oral** ibogaine + **IV magnesium** (support IV)—not psychoactive IV ibogaine proof, and not a stimulant approval package. See /blog/stanford-ibogaine-mistic.

What this site’s entity is **IV ibogaine infusion** = psychoactive intravenous delivery under physician supervision. Controlled evidence for that route remains sparse compared with oral observational series. Oral vs IV teaching: /blog/ibogaine-oral-vs-iv · Support vs psychoactive: /blog/electrolytes-support-iv-vs-psychoactive-iv.

Cardiac / QTc front for stimulant-interested readers

Stimulant use and ibogaine both touch cardiovascular risk. That is a stack, not a cancel.

• Ibogaine: QTc prolongation / arrhythmia concern (oral literature informs risk culture)
• Stimulants: tachycardia, hypertension, ischemia risk themes in broader medical practice
• Electrolytes, sleep deprivation, dehydration, and co-ingested QT-prolonging drugs compound risk

Screening hub: /safety-and-screening · Side effects: /blog/ibogaine-side-effects · Contraindications: /blog/ibogaine-contraindications · Interactions: /blog/ibogaine-drug-interactions-qtc.

No DIY ibogaine for cocaine comedowns. Unsupervised use is dangerous.

How this compares with standard stimulant-use care (high level)

Evidence-based care for cocaine/stimulant use disorder commonly emphasizes contingency management, behavioral therapies, treatment of co-occurring mood/ADHD/trauma where indicated, and medical management of complications. There is no FDA-approved ibogaine product for stimulants.

Ibogaine/noribogaine interest is investigational/exploratory relative to that standard—not a replacement slogan. Related spokes: /ibogaine-for-depression · /ibogaine-for-ptsd · fentanyl/opioid literacy /blog/ibogaine-for-fentanyl (different substance class—do not paste outcomes across).

Mexico provisional vs U.S. status for stimulant seekers

• U.S.: Schedule I / not FDA-approved; research headlines ≠ walk-in stimulant infusion clinics (/blog/is-ibogaine-legal-us).
• Provisional Mexico programs discussed on this site: not FDA/US clinics; demand route honesty and telemetry culture (/blog/ibogaine-mexico-medical-vs-tourism).
• Clinic vetting: /blog/how-to-choose-an-ibogaine-clinic · /blog/cheap-ibogaine-clinic-red-flags.
• Cost literacy: /blog/cost-of-ibogaine-treatment (market-reported ranges ≠ invoices; cash-pay abroad context).

Red-flag marketing aimed at cocaine/stimulant searches

Walk away (or slow down hard) when you hear:

1. “Guaranteed dopamine reset / lifelong cocaine cure”
2. Exact success percentages with no peer-reviewed denominator
3. “Stanford proved our IV stimulant protocol” (MISTIC = oral + IV Mg)
4. Pressure deposits before ECG/electrolytes/medication review
5. Refusal to put psychoactive route (oral vs IV) in writing
6. Advice to keep using stimulants up to infusion day “to feel the flood better”

Practical screening questions (stimulant context)

1. Recent ECG, electrolytes, and full medication/supplement list reviewed by a licensed clinician?
2. Any chest pain, syncope, arrhythmia history, or stimulant-associated cardiac events?
3. Polysubstance use (opioids, benzos, alcohol) disclosed and medically planned—not improvised?
4. Program clear whether dosing is oral or psychoactive IV?
5. Do they cite MISTIC correctly as oral + IV magnesium?
6. Do they refuse “forever sober after one session” for cocaine?
7. Is continuous cardiac monitoring and emergency transfer planned in writing?

Consent literacy twin: /blog/ibogaine-informed-consent-questions.

Soft CTA

If cocaine or stimulant research brought you here, start with medical safety—not cure ads. Read /safety-and-screening, then request a confidential screening consult via /apply. FAQ: /faq · Legality: /blog/is-ibogaine-legal-us.

FAQ

Does ibogaine cure cocaine addiction? No. No cure/guarantee claims. Evidence for stimulant use disorder remains limited relative to approval standards.

Is there an FDA-approved ibogaine treatment for cocaine or methamphetamine? No. Ibogaine is Schedule I federally and not FDA-approved for stimulants or any indication.

Did Stanford/MISTIC prove ibogaine for cocaine? No. MISTIC used **oral** ibogaine + **IV magnesium** in a small open-label veteran cohort—not a stimulant IV RCT.

Is published research mostly oral? Yes. Most human clinical literature reflects oral administration; controlled psychoactive-IV evidence is sparse.

Does QTc risk apply if my goal is stimulants, not opioids? Yes. Cardiac screening and monitoring remain central across indication discussions.

Can I DIY ibogaine for a cocaine binge crash? No. Dangerous. Seek licensed medical care for acute toxicity or withdrawal complications.

Are Mexico stimulant packages FDA clinics? No. Provisional Mexico programs discussed here are not FDA/US clinics. Not legal advice.

Where should I go next? /safety-and-screening then /apply.

Medical disclaimer

Educational evidence-limits summary only—not a detox protocol, medical advice, or legal advice. Do not self-administer ibogaine. Stimulant toxicity and ibogaine cardiac risks can both be life-threatening. Seek licensed clinicians.

Sources (selected)

1. Cherian K.N. et al. *Nature Medicine*. 2024 — oral ibogaine + IV magnesium (MISTIC); open-label; not stimulant IV proof.
2. Knuijver T. et al. *Addiction*. 2021 — oral ibogaine HCl; QTc findings in opioid-dependent open-label cohort.
3. Mosca A. et al. *Current Neuropharmacology* — limited RCTs; cardiotoxicity concerns.
4. 21 CFR 1308.11 — Schedule I (ibogaine).
5. Broader clinical landscape: no FDA-approved ibogaine indication for cocaine/stimulant use disorder as of last update.